Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Today, WebMD released My Abuelita Told Me, a new five-part video series developed in partnership with Dr. Juan Rivera (“Dr. Juan”), a board-certified internist and cardiologist, who is well-known for his best-selling books and regular appearances on broadcast television. My Abuelita Told Me explores the reliability of the various home remedies, beliefs and established practices that beloved abuelitas (a.k.a. grandmas) have passed down through the generations, and Dr. Juan clarifies what is or isn’t accurate using medical science.
To view the multimedia release go to:
https://www.multivu.com/players/English/7579758-webmd-my-abuelita-told-me-bilingual-video-series/
Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
In Carbide Tipped Pens, over a dozen of today’s most creative imaginations explore these frontiers, carrying on the grand tradition of such legendary masters as Isaac Asimov, Robert Heinlein, and John W. Campbell, while bringing hard science fiction into the 21st century by extrapolating from the latest scientific developments and discoveries. Find out more at http://us.macmillan.com/books/9780765334305. Science fiction
The National Inventors Hall of Fame®, in partnership with the United States Patent and Trademark Office (USPTO), will host the Greatest Celebration of American Innovation on May 3-4 in our Nation’s Capital. Events will recognize and celebrate 15 pioneers who have significantly contributed to society through their scientific breakthroughs and patented innovations, culminating in a formal Induction Ceremony on May 4.
This year’s class of Inductees includes innovators such as Iver Anderson (Lead-Free Solder), Marshall Jones (Industrial Lasers), Frances Ligler (Portable Optical Biosensors), and Howard Head (Laminate Ski; Oversized Tennis Racket), just to name a few. To view the full list of 2017 Inductees, visit: http://prn.to/2lgdW84.
To view the multimedia release go to:
https://www.multivu.com/players/English/8040951-national-inventors-hall-of-fame-2017/
The RCS Engineers Rocketry Team from Russellville, Ala., beat out 100 competitors to claim first place at the National Finals of the 2015 Team America Rocketry Challenge (TARC). After months of rocketry design, test flights and qualification launches, hundreds of students from across the country traveled to Great Meadow in the Plains, Va., to vie for the title of champion of the largest rocketry competition in the world.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7427051-team-america-rocketry-challenge/
Holland America Line turns its culinary programming up a notch with the introduction of dynamic shipboard cooking shows produced in partnership with the long-running public television show America’s Test Kitchen, the most popular how-to-cook show on TV. Holland America Line is a sponsor of America’s Test Kitchen on public television, and is proud to make this experience possible at sea. The initiative was announced today in New York City at a press conference at the prestigious Institute of Culinary Education.
Holland America Line’s shipboard Culinary Arts Center will be transformed to replicate the television set where the prominent America’s Test Kitchen TV shows are recorded for broadcast by more than 350 public television stations nationwide. Designed specifically for Holland America Line, the shipboard shows will be hosted by Holland America Line chefs trained by America’s Test Kitchen culinary experts. Shipboard cooking demonstrations and hands-on workshops — with topics ranging from shaping Asian dumplings to making the perfect pie crust — will combine foolproof, accessible recipes and cooking techniques that are rooted in the rigorous testing and science-based approach of America’s Test Kitchen.
To view the multimedia release go to:
http://www.multivu.com/players/English/7363858-americas-test-kitchen-joins-holland-america/
5 Reasons To Buy An Electric Car. Driving the 2016 Nissan Leaf, I discuss the many benefits of driving an electric vehicle. The instant torque and peak torque from 0 RPM, the incredibly low maintenance (tire rotations and cabin filter changes), the incredible efficiency (about 3x the efficiency of an ICE vehicle), the convenience of charging, and the affordability of leasing an electric car.
Related Videos
Nissan Leaf Review - https://youtu.be/KovdnzywQbs
Free Car? - https://youtu.be/NCdLFhUmubc
References:
Tribology International Study - http://www.sciencedirect.com/science/article/pii/S0301679X11003501
Fuel Economy Study - https://www.fueleconomy.gov/feg/evtech.shtml
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system.
The ClearSight system is a noninvasive monitor that provides clinicians access to valuable blood volume and blood flow information for patients at moderate or high risk of post-surgical complications, in whom invasive monitoring would not be used.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256451-edwards-fda-clearance-for-noninvasive-hemodynamic-monitoring-system/
When you’re a Super Reader, reading is super fun. And you can earn prizes too! Check out how to be a National Geographic Kids Super Reader at http://kids.nationalgeographic.com/explore/super-readers/
Encouraging, supportive, and educational, with 70+ leveled readers on people, science, animals, and nature. Kids
Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2016 Clinical Lab Expo today by featuring several next-generation diagnostic testing platforms and a new virtual reality experience that gives attendees an “under the hood” look at a lab of the future and an innovative concept Roche calls the “Roche connected lab.”
The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889151-roche-aacc-2016/
